CROI 2023: Metabolic and Other Complications of HIV Infection.
Top Antivir Med
; 31(4): 538-542, 2023 Jun 30.
Article
in En
| MEDLINE
| ID: mdl-37704199
ABSTRACT
Comorbid conditions have major impacts on the health, quality of life, and survival of people with HIV, particularly as they age. The 2023 Conference on Retroviruses and Opportunistic Infections (CROI) featured excellent science related to specific comorbidities, such as cardiovascular disease (CVD), cancer, and obesity. Studies investigating factors that may contribute to CVD, such as mental health disorders, antiretroviral therapies, and activation of hormonal pathways, were featured prominently. Other studies sought to understand the epidemiology of non-AIDS-defining cancers in people with HIV. As at previous CROI conferences, weight gain attributable to antiretroviral therapies was a major theme, and several abstracts focused on the important question of whether weight decreases after discontinuation of antiretroviral therapy (ART) regimens associated with weight gain. This review focuses on abstracts presented at CROI 2023 in these areas, highlighting those with the most clinical impact.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cardiovascular Diseases
/
HIV Infections
/
Retroviridae Infections
Type of study:
Etiology_studies
Limits:
Humans
Language:
En
Journal:
Top Antivir Med
Year:
2023
Type:
Article
Affiliation country:
United States